Sign up to save your podcasts
Or
Share NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
View all episodes
3.5
66 ratings